Key Players
C1 Inhibitor and Established HAE Product Providers
- CSL Behring
- Takeda Pharmaceutical Company Limited
- Pharming Group N.V.
Approved Alternative HAE Therapy Providers
- KalVista Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Ionis Pharmaceuticals, Inc.
Pipeline-Focused Challengers
- Intellia Therapeutics, Inc.
- Pharvaris N.V.
